TOP > News Release > Corporate
News Release

New Release Browse by Category

Corporate News Release

RSS
Browse by Year
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
Guide to Category Symbols
Corporate
R&D
Products
Others

2008

2008.05.13
Expansion of Business into Turkey and India
2008.05.13
DAIICHI SANKYO COMPANY Announces Executive-Change Candidate
2008.03.31
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
2008.03.05
Japanese pharmaceutical company acquires osteoporosis medication EVISTA from Lilly
DAIICHI SANKYO presses ahead with European expansion
2008.03.03
DAIICHI SANKYO Notice on Organizational Restructuring as of April 1, 2008
2008.02.15
DAIICHI SANKYO Notice concerning Determination of Certain Terms of the Issue Stock Options
(Stock Acquisition Rights) as Remuneration

2007

2007.12.21
DAIICHI SANKYO to Dissolve Subsidiary
2007.12.21
DAIICHI SANKYO Announces Merger of Subsidiaries
2007.11.30
Share Transfer of NIPPON NYUKAZAI and SINO-JAPAN CHEMICAL
(subsidiaries of DAIICHI SANKYO)
2007.10.26
DAIICHI SANKYO Announces the Revisions of Financial Forecasts for FY2007
2007.08.29
Deal for Irinotecan Hydrochloride with Yakult Honsha Terminates
2007.08.22
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
2007.07.31
DAIICHI SANKYO Announces Results of Share Buyback
2007.07.12
Fifth Sankyo Takamine Memorial Award Announced
2007.06.01
DAIICHI SANKYO to Acquire Own Shares
2007.05.25
DAIICHI SANKYO to award stock options as remuneration
2007.05.15
DAIICHI SANKYO COMPANY Announces Executive-Change Candidates
2007.05.08
Consolidated forecast for FY2007
2007.04.27
Revisions of Earnings Forecasts for FY 2006
2007.04.23
Daiichi Sankyo to Transfer all Daiichi Fine Chemical Shares to Kyowa Hakko
2007.04.23
Daiichi Sankyo to Transfer All Shares of Saitama Daiichi Pharmaceutical
2007.04.02
The transfer of all commercial rights for Panaldine(R)
2007.02.26
Sankyo to Transfer All Shares of MEGURO CHEMICAL INDUSTRY
2007.02.14
DAIICHI SANKYO Announces Midterm Management Plan for Fiscal 2007-2009

2006

2006.12.22
DAIICHI SANKYO Announces Result of Early Retirement Program
2006.12.06
Fourth Sankyo Takamine Memorial Award Announced
2006.11.30
Restructuring of Group Companies
2006.11.30
Daiichi Pharmaceutical to Transfer All Daiichi Medical Shares
2006.11.30
DAIICHI SANKYO Announces Simplified Merger with Subsidiaries
2006.11.06
Announcement of Personnel Appointments of Affiliates
2006.11.06
Announcement of new corporate officers
2006.10.27
Revisions of earnings forecasts for 1H FY 2006
2006.10.27
Business Transfer of the Chemical Products Business of Sankyo Lifetech (a subsidiary of Sankyo)
2006.10.23
Canadian Levofloxacin Patent Upheld by Federal Judge
2006.10.19
Spin-off and Share Transfer of the Animal Health Products Business of Sankyo Lifetech (a subsidiary of Sankyo)
2006.10.10
Daiichi Pharmaceutical Korea to Become Wholly Owned Subsidiary of Daiichi Pharmaceutical Co., Ltd.
2006.09.29
Spin-off and Share Transfer of the Businesses in Food Additive and
Drug Ingredients of Sankyo Lifetech (a subsidiary of Sankyo)
2006.09.29
DAIICHI SANKYO Subsidiaries Announce Early Retirement Program
2006.09.29
Transfer of Ameni-care Business of Sankyo Lifetech (a subsidiary of Sankyo) and Share Transfer of Sankyo Agro (a subsidiary of Sankyo)
2006.09.11
DAIICHI SANKYO to Transfer All Daiichi Pure Chemicals Shares
2006.09.11
DAIICHI SANKYO to Transfer All Daiichi Radioisotope Laboratories Shares
2006.09.08
DAIICHI SANKYO to Invest in the Healthcare Venture Fund
2006.08.31
Sankyo and Ajinomoto Reach Agreement on the Development, Manufacture and Marketing of the New Diabetes Drug, AJD101
2006.08.03
Daiichi Wins FLOXIN® Otic Patent Challenge by Generic Manufacturer Apotex
2006.08.02
Sales of Antihypertensive Agent Olmetec® Begin in China
2006.08.01
Daiichi Pharmaceutical to Develop and Market Anti-EGFr Drug Nimotuzumab in Japan
2006.07.14
Sankyo's European Subsidiaries' Names Change
2006.06.16
Sankyo's Chinese Subsidiary Acquires Medicine Management Certificate
2006.05.26
DAIICHI SANKYO to Amend the Articles of Incorporation
2006.05.26
DAIICHI SANKYO to Reduce Capital Reserves
2006.04.24
Acceptance of Tender Offer for Wakodo
2006.04.17
Additional Payment Determined for the Transfer of All Zepharma Stocks
2006.03.31
Acquisition of Stocks in Zepharma Inc.
2006.03.31
Announcement of Business Transfer to DAIICHI SANKYO HEALTHCARE
2006.03.30
Announcement of Revisions to Consolidated Financial Results for the Interim Period of Fiscal 2005
(Six-Month Period Ended September 30, 2005)
2006.03.30
Announcement of Revisions to Sankyo's Consolidated Financial Results for Prior Fiscal Years
2006.03.28
Announcement of the First DAIICHI SANKYO Group R&D Meeting
2006.03.23
Sankyo and Exelixis Sign Joint Research Agreement
2006.03.23
American Subsidiaries of Daiichi Pharmaceutical and Sankyo to Integrate
2006.02.17
Future Business Prospects of the Hyperlipidemia Drug Pravastatin in the United States
2006.01.31
Announcement of Revised Results Forecasts of the Sub-subsidiary Wakodo Co., Ltd.
2006.01.10
KAI Pharmaceuticals, Inc. and Sankyo Company, Limited Enter Global Alliance to Develop and Commercialize Novel Compounds for Cardiovascular Disease
2006.01.06
Stock Transfer of F.P. Processing Co., Ltd., a Subsidiary of Sankyo

2005

2005.12.22
Daiichi Defeats Mylan in Dispute Over $1 Billion Per Year Drug Patent
2005.12.14
Transfer of a Portion of Sankyo Pharma GmbH Products
2005.11.25
Establishment of the Healthcare Company
DAIICHI SANKYO HEALTHCARE CO., LTD.
2005.10.28
Announcement of Revised Results Forecasts of the Sub-subsidiary Wakodo Co., Ltd.
2005.10.17
Report concerning revisions to the forecasted results of our sub-subsidiary company (Fuji Flour Milling Co., Ltd.)
2005.09.28
Establishment of DAIICHI SANKYO COMPANY, LIMITED
Browse by Year
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others